Bronchodilators

  • I. F. Skidmore
Part of the Ettore Majorana International Science Series book series (EMISS, volume 14)

Asthma can be defined as a reversible increase in airways resistance associated with hyper-reactivity to irritant stimuli and with mechanical obstruction of flow in these airways. Although hyper-reactivity is an important determinant of the clinical response, little is known about its pathogenesis and treatment is directed mainly against obstruction. Physiological and pathological investigation of the disease shows that there are three main causes of obstruction; bronchoconstriction, inflammation and mucus production. In mild asthma bronchoconstriction predominates but as the disease increases in severity, inflammation and mucus become increasingly important until in status asthmaticus a combination of all three causes almost total obstruction.

Keywords

Adenylate Cyclase Status Asthmaticus Acute Severe Asthma Nocturnal Asthma Intravenous Salbutamol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Asthma (1977) (eds. T. J. H. Clark & S. Godfrey) Chapman and Hall Limited, London.Google Scholar
  2. 2.
    Skidmore, I.F. (1982). Allergic Asthma and Rhinitis: the relationship between pathobiology and treatment. Trends Pharmacol. Sci., 3, 66 – 70.CrossRefGoogle Scholar
  3. 3.
    Brittain, R. T., Dean, C. M., & Jack, D. (1981). Sympathomimetic Bronchodilator Drugs, in Respiratory Pharmacology pp. 613 – 655, (International Encyclopedia of Pharmacology and Therapeutics section 104. ed. J. G. Widdicombe). Pergamon Press, Oxford.Google Scholar
  4. 4.
    Ahlquist, R. P. (1948). A study of the adrenotropic receptors. Amer. J. Physiol., 153, 586 – 600.Google Scholar
  5. 5.
    Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F.P. & Brown, T. G. (1968). Differentiation of receptor systems activated by sympathomimetic amines. Nature (Lond). 214, 597 – 598.ADSCrossRefGoogle Scholar
  6. 6.
    Stull, J. T., Blumenthal, D. K., & Cooke, R. (1980). Regulation of contraction by myosin phosphorylation; a comparison between smooth and skeletal muscles. Biochem. Pharmac., 29, 2537 – 2543.CrossRefGoogle Scholar
  7. 7.
    Clark T. J. H. (1980). Diurnal variation in airway obstruction: clinical significance. IM Internal Medicine for the specialist, 1, 62 – 68.Google Scholar
  8. 8.
    Butchers, P. R., Skidmore, I. F., Vardey, C. J. & Wheeldon, A. (1980). Characterisation of the receptor mediating the antianaphylactic effects of adrenoceptor agonists in human lung <u>in vitro.</u> Br. J. Pharmac., 71, 663 – 667.CrossRefGoogle Scholar
  9. 9.
    McFadden Jnr., E. R., Soter, N. A. & Ingram Jnr., K. H. (1980). Magnitude and site of airway response to exercise in asthmatics in relation to histamine levels. J. Allergy Clin. Immunol., 66, 472 – 477.CrossRefGoogle Scholar
  10. 10.
    Levy, G. P., & Apperley, G. H. (1978). Recent advances in the pharmacological subclassification of adrenoceptors, in Recent Advances in the Pharmacology of Adrenoceptors. pp. 201 – 208. (eds. E. Szabadi, C. M. Bradshaw & P. Bevan) Elsevier/North Holland.Google Scholar
  11. 11.
    Prior, J. G., Cochrane, G. M., Raper, S. M., Ali, C. & Volans, G. N. (1981). Self-poisoning with oral salbutamol. Br. Med. J., 282, 1932.CrossRefGoogle Scholar
  12. 12.
    Harvey, J. E., Baldwin, C. J., Wood, P. J., Alberti, K. G. M. M. & Tattersf ield, A. (1981). Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin. Sci., 60, 579 – 585.Google Scholar
  13. 13.
    Long Term Theo phylline Therapy, (1980). Europ. J. Resp. Dis., 61, Supplement 109.Google Scholar
  14. 14.
    Fredholm, B. B. (1980). Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharm. Sci., 1, 129 – 132.CrossRefGoogle Scholar
  15. 15.
    Kolbeck, R. C., Speir, W. A., Carrier, G. O. & Bransome Jnr. E. D. (1979). Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline. Lung, 156, 173 – 183.CrossRefGoogle Scholar
  16. 16.
    Cardinali, D. P. (1980). Methylxanthines: possible mechanisms of action in the brain. Trends Pharmac. Sci., 1, 405 – 407.CrossRefGoogle Scholar
  17. 17.
    Persson, C. G. A., Erjefalt, I., & Karlsson, J. A. (1981). Adenosine antagonism, a less desirable characteristic of Xanthine asthma drugs. Acta Pharmac. Tox., 48, 317 – 320.Google Scholar
  18. 18.
    Svedmyr, K. (1981). 2 adrenoceptor stimulants and theophylline in asthma therapy. Europ. J. Resp. Dis. 62. Supplement 116.Google Scholar
  19. 19.
    Marlin, G. E., Hartnett, B. J. S., Berend, N., & Hacket, N. B. (1978). Assessment of combined oral theophylline and inhaled adrenoceptor agonist bronchodilator therapy. Br. J. Clin. Pharmac., 5, 45 – 50.CrossRefGoogle Scholar
  20. 20.
    Clark, C. J., & Boyd, G. (1980). Combination of aminophylline (Phyllocontin Continus Tablets) and salbutamol in the management of chronic obstructive airways disease. Br. J. Clin. Pharmac., 9, 359 – 364.CrossRefGoogle Scholar
  21. 1.
    Barnes, P. J., Greening, A.P., Neville, L., Timmers, J, & Poole, G. W. (1982). Single dose slow-release aminophylline at night prevents nocturnal asthma. Lancet 1: 229–301.Google Scholar
  22. 2.
    Barnes, P., Fitzgerald, G., Brown, M. & Dollery, C. (1980). Nocturnal asthma; changes in circulating epinephrine, histamine and cortisol. New Eng. J. Med., 303, 263–267.CrossRefGoogle Scholar
  23. 3.
    DeVries, K., Goei, J. T., Booij-Noord H, & Orie, N.G.M. (1962). Changes during 24 hours of the lung function and histamine hyperactivity of the bronchial tree in asthmatic and bronchitis patients. Int. Arch. Allergy, 20, 93–101.CrossRefGoogle Scholar
  24. 4.
    Peel, E. T. & Gibson, G. J. (1980), Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine. Am. Rev. Resp. Dis., 121, 973–977.Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • I. F. Skidmore
    • 1
  1. 1.Glaxo Group Research Limited WareHertfordshireUK

Personalised recommendations